Effect of Carvedilol on Survival in Severe Chronic Heart Failure

20013,078 citationsJournal Articlebronze Open Access

Authors

Milton Packer · Columbia University

Andrew J.S. Coats · Royal Brompton Hospital

Michael B. Fowler · Stanford Medicine

Hugo A. Katus · University of Lübeck

Henry Krum · Monash University

Paul Mohaçsi · University Hospital of Bern

Jean L. Rouleau ·

Abstract

The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also apparent in the patients with severe heart failure who were evaluated in this trial.

Topics & Keywords

Heart Failure Treatment and Management Cardiovascular Function and Risk Factors Blood Pressure and Hypertension Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 344, Issue 22, pp. 1651-1658

DOI: 10.1056/nejm200105313442201

Field-Weighted Citation Impact: 126.93